dc.contributor.author | Van Zyl, Danie G.![]() |
|
dc.date.accessioned | 2007-07-25T11:54:38Z | |
dc.date.available | 2007-07-25T11:54:38Z | |
dc.date.issued | 2006-11 | |
dc.description.abstract | Type 2 diabetes contributes to significant risk of cardiovascular and micro-vascular complications. The family practitioner plays a significant role in the management of glycaemic control and thereby reducing the related morbidity and mortality. Monitoring of blood glucose control has become an integral part of disease management that can empower patients and physicians to optimal blood glucose management. Numerous drugs are currently available to treat type 2 diabetic patients. The role of the currently available drugs is discussed as well as the use of insulin. A suggested protocol for the initiation and adjustment of treatment is provided. | en |
dc.format.extent | 261068 bytes | |
dc.format.mimetype | application/pdf | |
dc.identifier.citation | Van Zyl, DG 2006, 'Optimal glucose control in type 2 diabetes mellitus: a guide for the family practitioner', South African Family Practice, vol. 48, no. 10, pp. 22,24,26,28-29. [http://www.safpj.co.za/index.php/safpj] | en |
dc.identifier.issn | 1726-426X | |
dc.identifier.uri | http://hdl.handle.net/2263/3145 | |
dc.language.iso | en | en |
dc.publisher | Medpharm Publishers | en |
dc.rights | Medpharm Publishers | en |
dc.subject | Non-insulin dependent diabetes mellitus | en |
dc.subject | Glucose control | en |
dc.subject | Glycemic control | en |
dc.subject | Blood glucose | en |
dc.subject | Drug therapy | en |
dc.subject | Fasting glucose | en |
dc.subject | Sulfonylureas | en |
dc.subject | Meglitinidees | en |
dc.subject | Biguanide | en |
dc.subject | Thiazolidinediones | en |
dc.subject.lcsh | Diabetes | |
dc.subject.lcsh | Blood sugar monitoring | |
dc.subject.lcsh | Diabetes -- Oral therapy | |
dc.title | Optimal glucose control in type 2 diabetes mellitus - a guide for the family practitioner | en |
dc.type | Article | en |